NCT00604955View on ClinicalTrials.gov

Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

PHASE4CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2010

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Paromomycin sulfate

Paromomycin will be administered intramuscularly at 11 mg/kg, once a day, for 21 consecutive days

Trial Locations (7)

800 007

Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna

845 401

Shrimati Hazari Maternity and Medical Care, Azad Nagar, Balua Tal, Motihari

848 101

Research Centre for Diabetes, Hypertension and Obesity, Bengali Tola, Samastipur

Dr. A.K. Aditya Clinic, East of Bhola Talkies, Samastipur

800 001

Kala-zar Research Centre, Patna

842 001

Kala-azar Medical Research Centre, Rambagh Road, Muzaffarpur

842 003

Kalazar Research Centre, Brahmpura

All Listed Sponsors
lead

PATH

OTHER

NCT00604955 - Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis | Biotech Hunter | Biotech Hunter